A Novel Chimeric Protein with Enhanced Cytotoxic Effects on Breast Cancer In Vitro and In Vivo

The authors evaluated the inhibitory activity of the chimeric protein against breast cancer cells in vitro and in vivo. They developed a novel multifunctional protein, consisting of p28, as a tumor-homing killer peptide fused to apoptin as a tumor-selective killer.